Cerebral Angiography Market Size to Hit USD 2.27 Billion by 2033

Cerebral Angiography Market Size, Share, Growth, Trends, Opportunities, Segmental Analysis, Company Share Analysis, Leading Company Profiles, By Product Type (Cerebral Angiography Systems, Angiography Catheters, Contrast Media, Guidewires, Accessories), By Technology (Digital Subtraction Angiography, Magnetic Resonance Angiography, Computed Tomography Angiography, X-ray Angiography), By Procedure Type (Diagnostic Cerebral Angiography, Interventional Cerebral Angiography), By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers), By Indication (Stroke, Cerebral Aneurysm, Arteriovenous Malformations, Brain Tumors), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), and Market Forecast, 2026 – 2033

  • Published: Feb, 2026
  • Report ID: 1024
  • Pages: 180+
  • Format: PDF / Excel.

This report contains the Latest Market Figures, Statistics, and Data.

Get a Sample
logo

Cerebral Angiography Market Size to Hit USD 2.27 Billion by 2033

(An Updated Version is Available)

1. Executive Summary

  • 1.1 Market Overview

  • 1.2 Key Findings

  • 1.3 Market Size and Growth (2025–2033)

  • 1.4 Regional Snapshot

  • 1.5 Competitive Landscape Snapshot

  • 1.6 Market Dynamics Snapshot

2. Introduction

  • 2.1 Market Definition and Scope

  • 2.2 Study Assumptions and Base Year (2025)

  • 2.3 Forecast Period (2026–2033)

  • 2.4 Currency and Pricing

  • 2.5 Study Limitations

  • 2.6 Key Stakeholders

  • 2.7 Report Taxonomy

3. Research Methodology

  • 3.1 Research Framework

  • 3.2 Data Collection Methods

  • 3.3 Primary Research

    • 3.3.1 Key Industry Participants

    • 3.3.2 Breakdown of Primary Interviews

  • 3.4 Secondary Research

    • 3.4.1 Key Data Sources

  • 3.5 Market Size Estimation

    • 3.5.1 Top?Down Approach

    • 3.5.2 Bottom?Up Approach

  • 3.6 Data Triangulation and Validation

  • 3.7 Research Assumptions and Acronyms

4. Market Dynamics

  • 4.1 Market Overview

  • 4.2 Market Drivers

    • 4.2.1 Rising Prevalence of Cerebrovascular Disorders (Stroke, Aneurysms, AVMs)

    • 4.2.2 Advancements in Imaging Technology (DSA, 3D Rotational Angiography)

    • 4.2.3 Growing Demand for Minimally Invasive Diagnostic Procedures

    • 4.2.4 Aging Population and Increased Neurological Screening

  • 4.3 Market Restraints

    • 4.3.1 High Procedural and Equipment Costs

    • 4.3.2 Risk of Complications (Contrast Reactions, Radiation Exposure)

    • 4.3.3 Limited Access in Rural and Low?Resource Settings

  • 4.4 Market Opportunities

    • 4.4.1 Integration of AI and Machine?Learning in Image Analysis

    • 4.4.2 Development of Non?Contrast and Low?Radiation Imaging Techniques

    • 4.4.3 Expansion of Tele?Radiology and Remote Diagnostic Services

  • 4.5 Market Challenges

    • 4.5.1 Need for Skilled Interventional Radiologists and Technicians

    • 4.5.2 Managing Procedural Workflow and Patient Throughput

    • 4.5.3 Balancing Innovation with Reimbursement and Affordability

  • 4.6 Porter's Five Forces Analysis

    • 4.6.1 Threat of New Entrants

    • 4.6.2 Bargaining Power of Suppliers (Imaging Equipment, Contrast Agents)

    • 4.6.3 Bargaining Power of Buyers (Hospitals, Imaging Centers)

    • 4.6.4 Threat of Substitute Imaging Modalities (CT, MRI, Ultrasound)

    • 4.6.5 Intensity of Competitive Rivalry

  • 4.7 Value Chain Analysis

  • 4.8 Ecosystem and Stakeholder Map

5. Market Segmentation and Analysis

5.1 By Technology / Imaging Modality

  • 5.1.1 X?Ray Angiography

    • 5.1.1.1 Digital Subtraction Angiography (DSA)

    • 5.1.1.2 Conventional X?Ray Angiography

    • 5.1.1.3 3D Rotational Angiography

  • 5.1.2 Magnetic Resonance Angiography (MRA)

    • 5.1.2.1 Time?of?Flight (TOF) MRA

    • 5.1.2.2 Contrast?Enhanced MRA

  • 5.1.3 Computed Tomography Angiography (CTA)

  • 5.1.4 Ultrasound (Doppler Imaging)

  • 5.1.5 Nuclear Imaging (SPECT, PET)

5.2 By Indication / Clinical Application

  • 5.2.1 Stroke (Ischemic and Hemorrhagic)

  • 5.2.2 Aneurysms

  • 5.2.3 Arteriovenous Malformations (AVMs)

  • 5.2.4 Intracranial Stenosis and Atherosclerosis

  • 5.2.5 Tumors and Vascular Malformations

  • 5.2.6 Others

5.3 By Procedure Type

  • 5.3.1 Diagnostic Angiography

  • 5.3.2 Therapeutic / Interventional Angiography

5.4 By End?User

  • 5.4.1 Hospitals

    • 5.4.1.1 Neuro?Specialty Centers

    • 5.4.1.2 General Hospitals

  • 5.4.2 Diagnostic Imaging Centers

  • 5.4.3 Ambulatory Surgical Centers

  • 5.4.4 Research and Academic Institutions

5.5 By Patient Age Group

  • 5.5.1 Pediatric

  • 5.5.2 Adult

  • 5.5.3 Geriatric

5.6 By Distribution Channel

  • 5.6.1 Direct Sales (OEMs to Hospitals)

  • 5.6.2 Distributors and System Integrators

  • 5.6.3 Leasing and Rental Services

5.7 By Region

  • 5.7.1 North America

  • 5.7.2 Europe

  • 5.7.3 Asia Pacific

  • 5.7.4 Latin America

  • 5.7.5 Middle East & Africa

6. Regional Analysis

6.1 North America

  • 6.1.1 Market Overview and Key Trends

  • 6.1.2 Market Size and Forecast by Technology

  • 6.1.3 Market Size and Forecast by Indication

  • 6.1.4 Market Size and Forecast by Procedure Type

  • 6.1.5 Market Size and Forecast by End?User

  • 6.1.6 Market Size and Forecast by Patient Age Group

  • 6.1.7 Market Size and Forecast by Distribution Channel

  • 6.1.8 Country Analysis

    • 6.1.8.1 United States

    • 6.1.8.2 Canada

  • 6.1.9 Market Attractiveness Analysis

6.2 Europe

  • 6.2.1 Market Overview and Key Trends

  • 6.2.2 Market Size and Forecast by Technology

  • 6.2.3 Market Size and Forecast by Indication

  • 6.2.4 Market Size and Forecast by Procedure Type

  • 6.2.5 Market Size and Forecast by End?User

  • 6.2.6 Market Size and Forecast by Patient Age Group

  • 6.2.7 Market Size and Forecast by Distribution Channel

  • 6.2.8 Country Analysis

    • 6.2.8.1 Germany

    • 6.2.8.2 United Kingdom

    • 6.2.8.3 France

    • 6.2.8.4 Italy

    • 6.2.8.5 Spain

    • 6.2.8.6 Rest of Europe

  • 6.2.9 Market Attractiveness Analysis

6.3 Asia Pacific

  • 6.3.1 Market Overview and Key Trends

  • 6.3.2 Market Size and Forecast by Technology

  • 6.3.3 Market Size and Forecast by Indication

  • 6.3.4 Market Size and Forecast by Procedure Type

  • 6.3.5 Market Size and Forecast by End?User

  • 6.3.6 Market Size and Forecast by Patient Age Group

  • 6.3.7 Market Size and Forecast by Distribution Channel

  • 6.3.8 Country Analysis

    • 6.3.8.1 China

    • 6.3.8.2 Japan

    • 6.3.8.3 India

    • 6.3.8.4 South Korea

    • 6.3.8.5 Australia

    • 6.3.8.6 Rest of Asia Pacific

  • 6.3.9 Market Attractiveness Analysis

6.4 Latin America

  • 6.4.1 Market Overview and Key Trends

  • 6.4.2 Market Size and Forecast by Technology

  • 6.4.3 Market Size and Forecast by Indication

  • 6.4.4 Market Size and Forecast by Procedure Type

  • 6.4.5 Market Size and Forecast by End?User

  • 6.4.6 Market Size and Forecast by Patient Age Group

  • 6.4.7 Market Size and Forecast by Distribution Channel

  • 6.4.8 Country Analysis

    • 6.4.8.1 Brazil

    • 6.4.8.2 Mexico

    • 6.4.8.3 Rest of Latin America

  • 6.4.9 Market Attractiveness Analysis

6.5 Middle East & Africa

  • 6.5.1 Market Overview and Key Trends

  • 6.5.2 Market Size and Forecast by Technology

  • 6.5.3 Market Size and Forecast by Indication

  • 6.5.4 Market Size and Forecast by Procedure Type

  • 6.5.5 Market Size and Forecast by End?User

  • 6.5.6 Market Size and Forecast by Patient Age Group

  • 6.5.7 Market Size and Forecast by Distribution Channel

  • 6.5.8 Country/Sub?Region Analysis

    • 6.5.8.1 GCC Countries

    • 6.5.8.2 South Africa

    • 6.5.8.3 Rest of Middle East & Africa

  • 6.5.9 Market Attractiveness Analysis

7. Technology and Innovation Trends

  • 7.1 AI?Driven Image Analysis and Vascular Anomaly Detection

  • 7.2 Hybrid Operating Rooms with Integrated Angiography Systems

  • 7.3 Low?Radiation and Non?Contrast Imaging Advances

  • 7.4 Real?Time 3D and Biplane Angiography Systems

  • 7.5 Integration of Augmented Reality (AR) in Surgical Planning

  • 7.6 Tele?Angiography and Remote Diagnostic Platforms

8. Use Cases and Clinical?Practice Areas

  • 8.1 Acute Stroke Diagnosis and Intervention

  • 8.2 Pre?Surgical Mapping for Aneurysm and AVM Treatment

  • 8.3 Post?Operative and Follow?Up Vascular Imaging

  • 8.4 Diagnosis of Intracranial Atherosclerosis and Stenosis

  • 8.5 Tumor Vascularization Assessment

9. Regulatory and Reimbursement Landscape

  • 9.1 FDA, CE, and Other Regulatory?Agency Approvals for Imaging Devices

  • 9.2 Clinical Guidelines for Cerebral Angiography (AHA/ASA, ESO)

  • 9.3 Reimbursement Policies and Coverage Frameworks

  • 9.4 Impact of Regulations on Equipment Adoption and Clinical Access

10. Pricing and Business Models

  • 10.1 Cost?Structure Analysis (Equipment, Contrast, Procedure Fees)

  • 10.2 Pricing by Imaging Technology and System Configuration

  • 10.3 Direct?Sales vs. Leasing and Service?Contract Models

  • 10.4 Regional Pricing Differences and Reimbursement Variations

11. Competitive Landscape

  • 11.1 Market Competition Overview

  • 11.2 Market Share Analysis (2025–2033)

  • 11.3 Company Evaluation Matrix

  • 11.4 Competitive Benchmarking

  • 11.5 Market Concentration and Fragmentation

  • 11.6 Strategic Analysis

  • 11.7 Recent Developments

    • 11.7.1 New Product Launches and AI?Enhanced Imaging Platforms

    • 11.7.2 Partnerships with Hospitals and Imaging?Technology Providers

    • 11.7.3 Mergers, Acquisitions, and Technology Licensing

    • 11.7.4 Geographic Expansions and New Market Entries

12. Company Profiles

The final report includes a complete list of companies

  • 12.1 GE Healthcare

    • Company Overview

    • Financial Performance

    • Product Portfolio

    • Strategic Initiatives

    • SWOT Analysis

  • 12.2 Siemens Healthineers AG

  • 12.3 Koninklijke Philips N.V.

  • 12.4 Canon Medical Systems Corporation (Toshiba Medical)

  • 12.5 Shimadzu Corporation

  • 12.6 Hitachi Medical Corporation

  • 12.7 Samsung Medison

  • 12.8 Terumo Corporation

  • 12.9 Medtronic plc

  • 12.10 Stryker Corporation

  • 12.11 Boston Scientific Corporation

  • 12.12 AngioDynamics, Inc.

  • 12.13 Penumbra, Inc.

  • 12.14 MicroPort Scientific Corporation

  • 12.15 Other Key Cerebral?Angiography System Providers

13. Adjacent and Related Markets

  • 13.1 Neurovascular Devices and Interventional Radiology Market

  • 13.2 Medical Imaging Equipment Market (CT, MRI, Ultrasound)

  • 13.3 Contrast?Media and Diagnostic?Agent Market

  • 13.4 Stroke?Diagnosis and Neuro?Monitoring Market

14. Investment Analysis and Future Outlook

  • 14.1 Investment Trends and Funding in Neurovascular?Imaging Technologies

  • 14.2 Market Attractiveness by Segment and Region

  • 14.3 Emerging Growth Corridors (Asia Pacific, North America, Europe)

  • 14.4 Long?Term Growth Projections (2030–2033)

15. Go?to?Market and Business?Model Strategy

  • 15.1 Target Segments and Use Cases

  • 15.2 Preferred Sales and Distribution Channels

  • 15.3 Pricing and Packaging Strategies

  • 15.4 Key Success Factors for New Entrants

16. Appendix

  • 16.1 List of Abbreviations

  • 16.2 Glossary of Terms

  • 16.3 List of Tables

  • 16.4 List of Figures

  • 16.5 Related Reports

  • 16.6 Contact Information

17. Disclaimer

Enhance your decision-making capabilities with a 5 Reports-in-1
Bundle deal for - more than 40% off!

Our professional analysts will provide you with immediate assistance.